CMAC

CMAC is a world-class international hub for manufacturing research and training. Working in partnership with industry, its purpose is to transform current manufacturing processes into the medicine supply chain of the future.

Find out more

CMAC Response to Covid-19

In keeping with the latest government advice, CMAC have resumed lab activities and our collaborative research, training and translation programmes. Find out how CMAC are responding to the global Covid-19 pandemic.

Find out more
Business Case Insights for Continuous Manufacturing

CMAC and PwC are delighted to share ‘The Business Case Insights for Continuous Manufacturing’. This joint document, with input from industrial partners, seeks to review key considerations for building a successful business case for the industrial adoption of innovative Continuous Manufacturing (CM) technologies.

Find out more

Our Vision

CMAC’s vision is to revolutionise the way pharmaceuticals and high value products are made. The approaches developed and adopted within CMAC have been developed through close collaboration with industry and the support of its Tier 1 partners, which includes GlaxoSmithKline, AstraZeneca, Bayer, Lilly, Novartis, Pfizer, Roche and Takeda. Established in 2011, the CMAC has a £150m funding portfolio and currently comprises more than 130 staff and researchers, including academics, post docs, and more than 30 PhD students, as well as an experienced support team.

CMAC

  • conducts world class research in continuous manufacturing and advanced crystallisation;
  • conducts fundamental research;
  • develops new solutions to company specific problems;
  • delivers measurable successes that are of real benefit to society;
  • creates commercial opportunities for start-ups and major global companies;
  • produces a talent pipeline of highly skilled multi-disciplinary staff;
  • influences policy, government, and regulators;
  • understands and integrates with the broader supply chain context
  • collaborates with world class business and academia on an international basis.


 
Research

Industrially relevant research delivered by a multidisciplinary and collaborative academic team

Find out more
Award Winning Facility

Comprehensive suite of continuous processing, process analysis, and characterisation equipment housed in the Technology and Innovation Centre at Strathclyde

Find out more
Training & Skills

A vibrant world-class, multi-disciplinary PhD & MSc training programmes that will equip graduates with leading edge skills in pioneering continuous processes

Find out more
Translation to Industry

The demand-led manufacturing research scope of the Centre was co-created with our industry partners

Find out more

Events

RA in Data Science & Systems Integration for Medicines Development (391561) x2 posts
We are currently seeking applicants for two Research Associate posts based at the University of Strathclyde within Platform 1 – The Digital Platform. This Platform addresses one of the sector's core digitalisation challenges - a lack of large data sets and ways to access such data. The DM2 Data Platform will extract, store and analyse data from across the DM2 project, making it accessible, searchable and reusable for the medicines manufacturing community. New approaches for ensuring consistently high quality data, such as good practice guides and standards, will be developed alongside data science activities which will identify what the most important data are and how best to use them with IDTs in practice. The focus for these two roles will be the development and integration of new data-driven models to support the research in DM2 Platforms 1-4 alongside the creation of DM2 Data Services which make the tools accessible to the wider academic and pharmaceutical research sectors.





This is a unique opportunity to help realising the next generation of pharmaceutical data systems through the development of an integrated data platform that accelerates research and significantly increases of the value of data generated in R&D. You will work closely with the DM2 team and leading digital and pharmaceutical technology providers and global pharmaceutical companies.





You will have a PhD in a relevant subject (Pharmaceutical Sciences, Chemistry, Chemical Engineering, Computer Science or related discipline) with appropriate experience in data science and software engineering or related. You will develop novel models exploiting project data and develop data services which make tools and data more readily accessible to other software and researchers.





You must have excellent verbal and written communications skills with the ability to write clearly and succinctly for publication. You must also be able to work as a member of a research team, as well as demonstrate a successful track record of research achievement. You should be able to independently develop new concepts in your research, have excellent organisational skills, initiative, and the ability to pay close attention to detail.





Informal enquiries about the post can be directed to Prof Blair Johnston, DM² Co-I and Platform 1 Lead (blair.johnston@strath.ac.uk).





Formal interviews for this post will be held in September 2021.





To apply for this vacancy please visit: https://www.strath.ac.uk/workwithus/vacancies/





Closing Date: 03/09/2021








.... more

CMAC Business Development & Translation Manager (387401)
The Continuous Manufacturing and Advanced Crystallisation (CMAC) Hub is a world-class centre of excellence for advanced pharmaceutical manufacturing research and training. As an EPSRC Future Manufacturing Research Hub, led by the University of Strathclyde we work in close collaboration with a number of spokes at leading UK academic institutions (Bath, Cambridge, Imperial College, Leeds, Loughborough, Sheffield) and linking with international centres in the US, Europe and Far East. Working in partnership with industry, CMAC’s purpose is to transform the development and manufacture of medicines through advanced design and manufacturing technologies including the development of Digital Twins and MicroFactories. The four key pillars of CMAC’s program are to: deliver high quality manufacturing research; develop the workforce of the future through skills development and training; to drive effective translation of research into industry and, to continue to develop our world leading facilities and lab of the future infrastructure. As part of the University of Strathclyde, CMAC is also a strategic research partner for the Centre for Process Innovation’s (CPI) established Medicines Manufacturing Innovation Centre (MMIC).



CMAC’s demand led vision has been developed through close collaboration with our Tier 1 industry partners (GlaxoSmithKline, AstraZeneca, Novartis, Bayer, Takeda, Lilly, Pfizer, Roche) and a wide range of technology companies. Established in 2011, CMAC has contributed to a £150m funding portfolio and currently comprises more than 130 staff and researchers, including academics, post docs, PhD students as well as an experienced support team. Building on significant capital investments CMAC has established the National Facility team to broaden our ability to support and engage a wide user community within the £90M Technology & Innovation Centre (TIC) at Strathclyde.



This post offers an exciting opportunity to lead CMAC’s technical translation working effectively at the academic and industry interface. The Business Development (BD) & Translation Manager will deliver industry leading technical translation to Tier 1s and other National Facility users, engaging, maintaining and growing a sustainable pipeline of industry funding to support delivery of CMAC’s strategy and deliver the National Facility business plan.



You will be responsible for development and delivery of industry business engagement, Tier 1 Key Account Management (KAM) and non-Tier 1 business, and expansion of CMAC fee for services revenue through the CMAC National Facility. Reporting to the CMAC Industry Director, other duties will involve, project feasibility assessment, contractual management, and industry marketing and communications. Also, working in conjunction with the CMAC Director and National Facility Manger to ensure alignment in research capabilities, infrastructure, scheduling, skills and industry engagement strategies and maximise opportunities across CMAC. The post holder will ensure execution of CMAC’s Strategic Implementation Plan, Hub Pathways to Impact and CMAC National Facility translation activities.



The role is key in ensuring industry partners derive value from the program through appropriate routes (1-1, placements, core projects, CMAC Hub and research portfolio, translation projects) and create effective routes for knowledge exchange, IP generation or commercialisation routes to maximise the impact from research. A key interaction will be co-ordination of industry Technical Committees and ensuring effective and efficient running.



Informal enquiries about the post can be directed to Massimo Bresciani, Industry Director, massimo.bresciani@strath.ac.uk.



Click here for full details



To apply for this vacancy please visit: https://www.strath.ac.uk/workwithus/vacancies/



Closing Date: 26/08/2021.... more

RA in Natural Language Processing for Medicines Development (391554)
CMAC is a world leading medicines manufacturing research centre that hosts a portfolio of collaborative research programmes aimed to transform the development and manufacture of medicines (www.cmac.ac.uk). Building on our long standing partnerships with a wide range of pharmaceutical manufacturers, technology providers and leading universities, we are establishing a new EPSRC-funded Centre focussed on enabling digital transformation. The Made Smarter Innovation – Digital Medicines Manufacturing Research Centre (DM²) is a 3.5-year programme that will accelerate the adoption of industrial digital technologies (IDTs) in the pharma sector across five core Platforms covering data, advanced manufacturing, digital QC, patient centric supply and networking and skills. The DM² Centre connects a leading multidisciplinary team of researchers across Strathclyde, Loughborough and Cambridge universities with leading digital technology providers, medicines manufacturers and healthcare providers, to drive a digital transformation in medicines manufacturing.



The five integrated Platforms designed by the academic and industrial researcher partners are: (1) The Data Platform; (2) Autonomous MicroScale Manufacturing Platform; (3) Digital Quality Control Platform; (4) Adaptive Digital Supply Platform; and (5) The DM² Network & Skills Platform.



This ambitious programme is supported by a large team of Post-doctoral Research Associates, Research Technicians and management staff to plan, deliver and disseminate the ambitious research, networking and training activities.



We are currently seeking applicants for a PDRA post based at the University of Strathclyde within Platform 1 – The Digital Platform. This Platform addresses one of the sector's core digitalisation challenges - a lack of large data sets and ways to access such data. The DM² Data Platform will extract, store and analyse data from across the DM² project, making it accessible, searchable and reusable for the medicines manufacturing community. New approaches for ensuring consistently high quality data, such as good practice guides and standards, will be developed alongside data science activities which will identify what the most important data are and how best to use them with IDTs in practice. The focus of this role will be the development of tools for automated extraction of information from the medicines manufacturing literature and partners’ data systems.



This is a unique opportunity to help realising the next generation of pharmaceutical data systems through the development of an integrated data platform that accelerates research and significantly increases the value of data generated in R&D. You will work closely with the DM² team and leading digital and pharmaceutical technology providers and global pharmaceutical companies.



You will have a PhD in a relevant subject (Computer Science with emphasis on Software Engineering and Text Mining or related discipline) with appropriate experience in information extraction, terminology management, text classification, text mining infrastructures and semantic search systems. You will develop interoperable text mining infrastructure specifications, design the architecture of text mining platforms, develop and integrate text mining tools for the project’s use cases with other domain experts.



You must have excellent verbal and written communications skills with the ability to write clearly and succinctly for publication. You must also be able to work as a member of a research team, as well as demonstrate a successful track record of research achievement. You should be able to independently develop new concepts in your research, have excellent organisational skills, initiative, and the ability to pay close attention to detail.



Informal enquiries about the post can be directed to Prof Blair Johnston, DM² Co-I & Platform 1 Lead, blair.johnston@strath.ac.uk.



Click here for full details



To apply for this vacancy please visit: https://www.strath.ac.uk/workwithus/vacancies/



Closing Date: 29/08/2021.... more

News

Funding Announcement: Made Smarter Innovation Digital Medicines Manufacturing Research Centre
Funding Announcement: Made Smarter Innovation - Digital Medicines Manufacturing Research Centre







CMAC are delighted to announce a new £5M award from EPSRC to establish and lead the new Made Smarter Innovation - Digital Medicines Manufacturing Research Centre (DM2). This award continues to build CMAC’s research portfolio and is part of the UKRI and Made Smarter Innovation £53 million investment in smart manufacturing and connected supply chain research and innovation. .... more

MIT-CMAC International Symposium on Continuous Manufacturing of Pharmaceuticals
An Integrated Ecosystem for Transforming Medicines Manufacturing





February’s meeting, jointly run between MIT and CMAC Future Manufacturing Research Hub, brought together over 350 pharmaceutical industrialists, regulators, policy makers and academics from more than 22 countries and 142 organisations to inform strategies to grow medicines manufacturing in the UK and internationally, through accelerating the adoption of advanced manufacturing and digital technologies..... more

Laminar and UK/IRE Distributor Analytik Join CMAC Future Manufacturing Research Hub
Continuous flow chemical reactor manufacturer Laminar Co Ltd (Jungwon-gu, Republic of Korea), represented in the UK and Ireland by Analytik Ltd (Cambridge, UK), have joined the CMAC Future Manufacturing Research Hub as tier 2 members from October 2020..... more